[Guidelines for cell therapy to treat urinary incontinence]

Area of Science:

• Regenerative Medicine
• Urology
• Cell-Based Therapies

Context:

• Urinary incontinence is a prevalent condition affecting millions globally.
• Cell therapy is an emerging treatment modality for stress urinary incontinence.
• Existing clinical trials exhibit variability in cell preparation and patient selection.

Purpose:

• To review the current status of cell therapy for urinary incontinence.
• To assess the feasibility and limitations of cell-based treatments.
• To guide future research and clinical application.

Summary:

• Multiple clinical trials have explored cell therapy for urinary incontinence, demonstrating feasibility.
• Significant variations exist in cell preparation methods and patient inclusion criteria across studies.
• Indications for treatment and long-term efficacy remain to be established.

Impact:

• Cell therapy for urinary incontinence is currently investigational and best pursued within clinical trials.
• Standardization of protocols and long-term outcome data are crucial for clinical adoption.
• Collaboration and data sharing among researchers are essential for advancing the field.